15
Views
18
CrossRef citations to date
0
Altmetric
Research Article

The presence of progesterone receptors in arachnoid granulations and in the lining of arachnoid cysts: its relevance to expression of progesterone receptors in meningiomas

Pages 47-50 | Published online: 06 Jul 2009

  • Roelvink NCA, Kamphorst W, Van Alphen HAM, Rao BR. Pregnancy-related primary brain and spinal tumors. Arch Neurol 1987; 44:209-15.
  • Haak HR, De Keizer RJW, Hagenouw-Taal JCW, Van Seters AP, Vielvoye GJ, Van Dulken H. Successful mifepristone treatment of recurrent, inoperable meningioma. Lancet 1990; 336:124-5.
  • Grunberg SM, Weiss MH, Spitz IM, et al. Treatment of unresectable meningiomas with the an-tiprogesterone agent mifepristone. J Neurosurg 1991; 74:861-6.
  • Lamberts SWJ, Tanghe HLJ, Avezaat CJJ, et al. Mifepristone (RU 486) treatment of meningiomas. J Neurol Neurosurg Psychiatry 1992; 55:486-90.
  • Verhagen A, Elsinga PH, De Groot TJ, et al. A [18F]¯ uorine labeled progestin as an imaging agent for progestin receptor positive tumors with positron emission tomography. Cancer Res 1991; 51:1930-3.
  • Verhagen A, Luurtsema G, Pesser JW, et al. Preclinical evaluation of a positron emitting progestin ([18F]¯ uor-16a-methyl-19-norprogesterone)for imaging progesterone receptor positive tumours with positron emission tomography. Cancer Lett 1991; 59:125-32.
  • Verhagen A. [18F]¯ uorine labeled progestins as potential radiopharmaceuticals for progesterone receptor positive tumors with positron emission tomography.Dissertation,StateUniversityof Groningen, 1993.
  • Kepes JJ. The histopathology of meningiomas. A re¯ ection of origins and expected behavior? J Neu-ropathol Exp Neurol 1986; 45:95-107.
  • Go KG, Houthoff HJ, Blaauw EH, Stokroos I, Blaauw G. Morphology and origin of arachnoid cysts. Scanning and transmission electron microscopy of three cases. Acta Neuropathol (Berl) 1978; 44:57-62.
  • Go KG, Houthoff HJ, Blaauw EH, Havinga P, Hartsuiker J. Arachnoid cysts of the Sylvian fissure. Evidence of ¯ uid secretion. J Neurosurg 1984; 60:803-13.
  • EORTC Breast Cancer Cooperative Group. Revision of the standards for the assessment of hormone receptors in human breast cancer. Eur J Cancer 1980; 16:1513-15.
  • Blankenstein MA, Van der Meulen-Dijk C, Thijs-sen JHH. Assay of oestrogen and progestin receptorsinhumanmeningiomacytosolsusing immunological methods. Clin Chim Acta 1987; 165:189-95.
  • Poisson M, Magdelenat H, Martin PM, et al. Re-cepteurs de la progesteÂrone de la leptomeÂninge humaine normale chez l‘adulte. Rev Neurol (Paris) 1984; 140:14-9.
  • Verhagen A, Studeny M, Luurtsema G, et al. Metabolism of a [18F] ¯ uorine labeled progestin (21-[18F] ¯ uoro-16a-ethyl-19-norprogesterone) in humans: a clue for future investigations. Nucl Med Biol 1944; 21:941 -52.
  • Russell DS, Rubinstein LJ. Pathology of tumours of the nervous system, 5th edn. London: Edward Arnold, 1989:498 -500.
  • Kato J. Progesterone receptors in brain and hypophysis. In: Ganten D, Pfaff D, eds. Actions of progesterone on the brain. Berlin: Springer Verlag, 1985:31-81.
  • Love JA, FrideÂn H, Ekstedt J. The effect of corticosteroids at the level of the arachnoid ville. In: Go KG, Beathmann A, eds. Recent progress in the study and therapy of brain edema. New York: Plenum Press, 1984:589 -95.
  • Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 1986; 232:1004 -7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.